Search all medical codes

Fibrin(ogen) degradation (split) products (FDP) (FSP); agglutination slide, semiquantitative

CPT4 code

Name of the Procedure:

Fibrin(ogen) Degradation (Split) Products (FDP) (FSP); Agglutination Slide, Semiquantitative

Summary

This procedure measures the levels of fibrinogen degradation products (FDP) in the blood using an agglutination slide test. FDPs are fragments produced when a blood clot dissolves in the body, and their presence can give important information about clotting activity.

Purpose

The test helps to identify and monitor disorders related to abnormal blood clotting, such as disseminated intravascular coagulation (DIC) or deep vein thrombosis (DVT). The goal is to understand clotting conditions better and guide appropriate management.

Indications

  • Unexplained bleeding or bruising
  • Symptoms suggestive of blood clot disorders
  • Conditions like sepsis or trauma where DIC might be a risk
  • Monitoring response to treatment for clotting disorders

Preparation

  • No specific fasting or dietary restrictions required.
  • Inform healthcare provider about all medications being taken, as some might interfere with test results.
  • Blood sample might be needed for initial evaluation.

Procedure Description

  1. The procedure begins with a blood draw, typically from a vein in your arm.
  2. The blood sample is then mixed with reagents on an agglutination slide.
  3. Technicians observe the slide to see if clumping (agglutination) occurs, indicating the presence of FDPs.
  4. Results are measured semi-quantitatively, indicating the level of FDPs.

Tools and Equipment:

  • Sterile syringe and needle for blood draw
  • Agglutination slide and reagents
  • Microscope for slide observation

Duration

The procedure itself takes about 5-10 minutes, but full processing of results might take several hours.

Setting

Typically performed in a hospital laboratory or a specialized outpatient clinic.

Personnel

  • Phlebotomist or nurse for drawing blood
  • Laboratory technicians or pathologists for analyzing the sample

Risks and Complications

  • Minor discomfort or bruising at the blood draw site
  • Rare risk of infection at the puncture site

Benefits

  • Provides valuable information about clotting activity in the body
  • Helps diagnose serious conditions like DIC or DVT
  • Guides treatment decisions to prevent complications

Recovery

  • No significant recovery is needed.
  • Keep the puncture site clean and monitor for any signs of infection.
  • Follow-up appointments might be scheduled based on results.

Alternatives

  • D-dimer tests for monitoring blood clots
  • Imaging studies like ultrasound for locating blood clots
  • Each alternative has specific pros and cons depending on the suspected condition.

Patient Experience

During the procedure, you might feel a slight sting when the needle is inserted for blood draw. There is minimal discomfort involved. Post-procedure, you can proceed with normal activities, though slight bruising may be observed at the puncture site. Pain is generally minimal and requires little to no intervention.

Pain Management and Comfort Measures:

  • Ensure relaxation during the blood draw.
  • Apply pressure and a bandage post-draw to minimize bruising and bleeding.

Medical Policies and Guidelines for Fibrin(ogen) degradation (split) products (FDP) (FSP); agglutination slide, semiquantitative

Related policies from health plans

Similar Codes